TRIMEDX-AIQ delivers unmatched visibility, predictive intelligence, and supply chain automation - enabling 10-20% clinical ...
The CSIR teams up with PromptBio to accelerate AI-driven multiome research for various disease groups in Africa.
The researchers developed a non-invasive visual edge module capable of automatically gathering physiological data from ...
According to a statement, the partnership will enhance integrated multiome data analysis and AI-powered insights for the ...
Policymakers across Europe and the United States are moving to classify many clinical AI tools as high-risk systems, ...
A flurry of deal-making hasn’t let up as 2025 comes to a close, with Roche subsidiary Genentech getting in on the action and ...
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year ...
FDA approves CBI-1214 for colorectal cancer, enabling fast-tracked clinical trials and highlighting innovative T-cell engager ...
BMS signed a multiyear agreement with antibody specialist Harbour BioMed, which has operations in the US, the Netherlands, ...
Baylor College of Medicine will be a site for a new multi-institution project aimed at investigating preclinical drug safety ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that its therapeutic research arm, Caris Discovery, ...
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback